Abstract |
To investigate the pathogenic mechanism of ulcerative colitis, a dextran sulfate sodium (DSS)-induced acute colitis model was examined by serum metabolomic analysis. Higher levels of stearoyl lysophosphatidylcholine and lower levels of oleoyl lysophosphatidylcholine in DSS-treated mice compared to controls led to the identification of DSS-elicited inhibition of stearoyl-CoA desaturase 1 (SCD1) expression in liver. This decrease occurred prior to the symptoms of acute colitis and was well correlated with elevated expression of proinflammatory cytokines. Furthermore, Citrobacter rodentium-induced colitis and lipopolysaccharide treatment also suppressed SCD1 expression in liver. Scd1 null mice were more susceptible to DSS treatment than wild-type mice, while oleic acid feeding and in vivo SCD1 rescue with SCD1 adenovirus alleviated the DSS-induced phenotype. This study reveals that inhibition of SCD1-mediated oleic acid biogenesis exacerbates proinflammatory responses to exogenous challenges, suggesting that SCD1 and its related lipid species may serve as potential targets for intervention or treatment of inflammatory diseases.
|
Authors | Chi Chen, Yatrik M Shah, Keiichirou Morimura, Kristopher W Krausz, Makoto Miyazaki, Terrilyn A Richardson, Edward T Morgan, James M Ntambi, Jeffrey R Idle, Frank J Gonzalez |
Journal | Cell metabolism
(Cell Metab)
Vol. 7
Issue 2
Pg. 135-47
(Feb 2008)
ISSN: 1550-4131 [Print] United States |
PMID | 18249173
(Publication Type: Journal Article, Research Support, N.I.H., Intramural)
|
Chemical References |
- Phosphatidylcholines
- Dextran Sulfate
- Scd1 protein, mouse
- Stearoyl-CoA Desaturase
|
Topics |
- Animals
- Colitis
(etiology)
- Dextran Sulfate
- Disease Models, Animal
- Down-Regulation
- Inflammation
(etiology)
- Lipid Metabolism
(physiology)
- Liver
(metabolism)
- Mice
- Phosphatidylcholines
(analysis)
- Stearoyl-CoA Desaturase
(antagonists & inhibitors, deficiency)
|